Sign Up for Our Newsletter
New York 65 F
overcast clouds
November 30, 2025
Newsflash:
U.S. tech stocks slide on AI bubble fears10:45 AM
Government Shutdown Halts SNAP Benefits 8:00 AM
UPS Cargo Plane Crash in Kentucky Kills 7 2:45 AM
Democrats Gain in 2025 State Elections 10:00 PM
USPTO Stays Open Amid Federal Shutdown 9:30 AM
US–China Reach Rare-Earth Trade Accord 11:15 AM
Clocks “Fall Back” as Daylight Saving Time Ends 2:00 AM
Federal Government Shutdown Surpasses Historic Milestone12:01 AM
Insurtech Firm to Release Q3 Results 5:00 PM
“Make-or-Break Day” for Million's Finances 12:00 AM
SpaceX Prepares for next-icon Starship Launch 10:14 am
Julio Rodríguez Can Fly. Will His Bat Ground Him? 10:11 am
SpaceX Prepares for next-icon Starship Launch 10:14 am
Reid Ashton is a health news writer in the U.S. who writes about new medical policies, public health trends, and major scientific breakthroughs. He writes about new ideas in healthcare, the FDA's decisions, and policy changes that affect patients, hospitals, and doctors all throughout the country. His reporting brings us correct, research-based information regarding new diseases, progress in biotechnology, and the future of public health in the US.
FDA launches a new regulatory pathway to approve personalized gene and cell therapies using smaller patient data sets, accelerating access for rare diseases and unmet medical needs.
Nov 12
by Reid Ashton
